drugset / Trial / NCT00022477

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00022477

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have recurrent or metastatic colorectal cancer.

Timeline

Start
2001-09
Primary completion
2002-10
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous

Indications